The naturalistic course of anxiety and depressive disorders.

Anxiety in depressive disorders.

[Anxiety-depressive disorders and bronchiectasis].

Naturalistic follow-up of youths treated for pediatric anxiety disorders.

Perfectionism in pediatric anxiety and depressive disorders.

P300 findings for depressive and anxiety disorders.

Symptom comorbidity in anxiety and depressive disorders.

The Relationship of Hypochondriasis to Anxiety, Depressive, and Somatoform Disorders.

PATHOLOGICAL PERSONALITY TRAITS AND THE NATURALISTIC COURSE OF INTERNALIZING DISORDERS AMONG HIGH-RISK YOUNG ADULTS.

Prevalence and course of depressive disorders in hospitalized stroke patients.

Chronic course of anxiety disorders in children and adolescents.

[Comorbid depressive and anxiety disorders in patients with cancer].

Serotonin-specific drugs for anxiety and depressive disorders.

The trajectories of adolescent anxiety and depressive symptoms over the course of a transdiagnostic treatment.

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders.

Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.

Anxiety and depressive symptoms and medical illness among adults with anxiety disorders.

12-Month naturalistic outcomes of depressive disorders in Hong Kong's primary care.

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders.

Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study.

Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.

Diabetes Mellitus and the Risk of Depressive and Anxiety Disorders in Australian Women: A Longitudinal Study.

The impact of comorbid depressive and anxiety disorders on severity of anorexia nervosa in adolescent girls.

The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.

Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders.

Suggest Documents

Anxiety in depressive disorders.

[Anxiety-depressive disorders and bronchiectasis].

Naturalistic follow-up of youths treated for pediatric anxiety disorders.

Perfectionism in pediatric anxiety and depressive disorders.

P300 findings for depressive and anxiety disorders.

Symptom comorbidity in anxiety and depressive disorders.

The Relationship of Hypochondriasis to Anxiety, Depressive, and Somatoform Disorders.

PATHOLOGICAL PERSONALITY TRAITS AND THE NATURALISTIC COURSE OF INTERNALIZING DISORDERS AMONG HIGH-RISK YOUNG ADULTS.

Prevalence and course of depressive disorders in hospitalized stroke patients.

Chronic course of anxiety disorders in children and adolescents.

[Comorbid depressive and anxiety disorders in patients with cancer].

Serotonin-specific drugs for anxiety and depressive disorders.

The trajectories of adolescent anxiety and depressive symptoms over the course of a transdiagnostic treatment.

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders.

Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.

Anxiety and depressive symptoms and medical illness among adults with anxiety disorders.

12-Month naturalistic outcomes of depressive disorders in Hong Kong's primary care.

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders.

Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study.

Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.

Diabetes Mellitus and the Risk of Depressive and Anxiety Disorders in Australian Women: A Longitudinal Study.

The impact of comorbid depressive and anxiety disorders on severity of anorexia nervosa in adolescent girls.

The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.

Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders.

The naturalistic course of anxiety and depressive disorders.

Recommend Documents

Follow Us